دوره 33، شماره 161 - ( 9-1404 )                   جلد 33 شماره 161 صفحات 292-284 | برگشت به فهرست نسخه ها

XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kazem H M, Faraj H R, Hussein T K. Biochemical Study of Norepinephrine and Selected Trace Elements in Children with Autism and Attention Deficit Hyperactivity Disorder in Thi- Qar Governorate, Iraq. J Adv Med Biomed Res 2025; 33 (161) :284-292
URL: http://journal.zums.ac.ir/article-1-7843-fa.html
Biochemical Study of Norepinephrine and Selected Trace Elements in Children with Autism and Attention Deficit Hyperactivity Disorder in Thi- Qar Governorate, Iraq. Journal of Advances in Medical and Biomedical Research. 1404; 33 (161) :284-292

URL: http://journal.zums.ac.ir/article-1-7843-fa.html


چکیده:   (421 مشاهده)

Background & Objective: Autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) are prevalent neurodevelopmental conditions characterized by cognitive, behavioral, and social impairments. Both disorders may involve disturbances in catecholamine regulation and trace element homeostasis. This study evaluated serum norepinephrine levels and selected trace elements (zinc, iron, magnesium, and copper) in children with ASD or ADHD compared with healthy controls in Thi-Qar Governorate, Iraq.
 Materials & Methods: A case-control study was conducted between January 2024 and February 2025 and included 170 children aged 3 to 13 years: 55 with ASD, 60 with ADHD, and 55 healthy controls. Blood samples were obtained at the Autism Center in Thi-Qar Governorate and Shatra General Hospital under specialist supervision, following standard collection protocols. Serum norepinephrine and mineral concentrations were analyzed using validated biochemical methods.
Results:  Children with ASD and ADHD demonstrated significantly elevated norepinephrine levels compared with controls (P <0.05). Concentrations of zinc, iron, and magnesium were significantly reduced (P <0.05), whereas copper levels were markedly increased in both clinical groups relative to healthy participants.
Conclusion:  The findings indicate notable neurochemical and mineral alterations in children with ASD and ADHD. These results underscore the potential diagnostic value of norepinephrine and trace elements as biochemical markers and suggest the need for targeted nutritional and therapeutic interventions.

متن کامل [PDF 506 kb]   (11 دریافت)    
نوع مطالعه: مقاله پژوهشی | موضوع مقاله: Clinical Medicine
دریافت: 1404/5/22 | پذیرش: 1404/7/28 | انتشار: 1404/9/21

فهرست منابع
1. Kawass G. Association" neurotoxicity" of Toxic Metal Mercury in Hair with Autism Spectrum Disorders in Children. Univ Thi-Qar J Sci. 2024;11(1):203-6. [DOI:10.32792/utq/utjsci/v11i1.1216]
2. Li J, You Y, Yue W, Jia M, Yu H, Lu T, et al. Genetic evidence for possible involvement of the calcium channel gene CACNA1A in autism pathogenesis in Chinese Han population. PLoS One. 2015;10(11):e0142887. [DOI:10.1371/journal.pone.0142887] [PMID] [PMCID]
3. Abbas FN, Munshed FA, Issa AH. Gut Flora in Autistic Children as Biomarker for Autism in Thi-Qar Province/Iraq. Univ Thi-Qar J Sci. 2020;7(2):73-9. [DOI:10.32792/utq/utjsci/v7i2.717]
4. Song P, Zha M, Yang Q, Zhang Y, Li X, Rudan I. The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis. J Glob Health. 2021;11:04009. [DOI:10.7189/jogh.11.04009] [PMID] [PMCID]
5. Gogne A. Clinical assessment. InNeurodevelopmental Disorders in Adult Women: Special Considerations in the Perinatal Period 2025 Apr 2 (pp. 45-101). Cham, Switzerland: Springer Nature. [DOI:10.1007/978-3-031-86588-6_4]
6. Koevoet D, Deschamps PK, Kenemans JL. Catecholaminergic and cholinergic neuromodulation in autism spectrum disorder: A comparison to attention-deficit hyperactivity disorder. Front Neurosci. 2023;16:1078586. [DOI:10.3389/fnins.2022.1078586] [PMID] [PMCID]
7. Leshem R, Bar-Oz B, Diav-Citrin O, Gbaly S, Soliman J, Renoux C, et al. Selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) during pregnancy and the risk for autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) in the offspring: a true effect or a bias? A systematic review & meta-analysis. Current Neuropharmacology. 2021;19(6):896-906. [DOI:10.2174/1570159X19666210303121059] [PMID] [PMCID]
8. Koevoet D, Deschamps PK, Kenemans JL. Catecholaminergic and cholinergic neuromodulation in autism spectrum disorder: A comparison to attention-deficit hyperactivity disorder. Front Neurosci. 2023;16:1078586. [DOI:10.3389/fnins.2022.1078586] [PMID] [PMCID]
9. Moraes AC, Wijaya C, Freire R, Quagliato LA, Nardi AE, Kyriakoulis P. Neurochemical and genetic factors in panic disorder: a systematic review. Transl Psychiatry. 2024;14(1):294. [DOI:10.1038/s41398-024-02966-0] [PMID] [PMCID]
10. Shayganfard M. Are essential trace elements effective in modulation of mental disorders? Update and perspectives. Biol Trace Elem Res. 2022;200(3):1032-59. [DOI:10.1007/s12011-021-02733-y] [PMID]
11. Hassouni SA, Ahmed JT, Mohammed SJ. Effect of Socio-Demographic Characteristics on Level of Zinc in Serum of Adults in Najaf. Univ Thi-Qar J Sci. 2023;10(1 (SI)):25-32. [DOI:10.32792/utq/utjsci/v10i1(SI).955]
12. do Nascimento PK, Oliveira Silva DF, de Morais TL, de Rezende AA. Zinc status and autism spectrum disorder in children and adolescents: a systematic review. Nutrients. 2023;15(16):3663. [DOI:10.3390/nu15163663] [PMID] [PMCID]
13. Kulaszyńska M, Kwiatkowski S, Skonieczna-Żydecka K. The iron metabolism with a specific focus on the functioning of the nervous system. Biomedicines. 2024;12(3):595. [DOI:10.3390/biomedicines12030595] [PMID] [PMCID]
14. Pongpitakdamrong A, Chirdkiatgumchai V, Ruangdaraganon N, Roongpraiwan R, Sirachainan N, Soongprasit M, et al. Effect of iron supplementation in children with attention-deficit/hyperactivity disorder and iron deficiency: a randomized controlled trial. J Dev Behav Pediatr. 2022;43(2):80-6. [DOI:10.1097/DBP.0000000000000993] [PMID]
15. Garcia-Casal MN, Pasricha SR, Martinez RX, Lopez-Perez L, Peña-Rosas JP. Serum or plasma ferritin concentration as an index of iron deficiency and overload. Cochrane Database Syst Rev. 2021;5(5):CD011817. [DOI:10.1002/14651858.CD011817.pub2] [PMID] [PMCID]
16. Faisal S. The Relationship Between Iron Deficiency and Asthma Severity: Detection The Role of Gender and Ferritin Level. Univ Thi-Qar J Sci. 2024;11(2):142-6. [DOI:10.32792/utq/utjsci/v11i2.1269]
17. Kumar A, Mehan S, Tiwari A, Khan Z, Das Gupta G, Narula AS, et al. Magnesium (Mg2+): Essential mineral for neuronal health: From cellular biochemistry to cognitive health and behavior regulation. Curr Pharm Des. 2024;30(39):3074-107. [DOI:10.2174/0113816128321466240816075041] [PMID]
18. Effatpanah M, Rezaei M, Effatpanah H, Effatpanah Z, Varkaneh HK, Mousavi SM, et al. Magnesium status and attention deficit hyperactivity disorder (ADHD): A meta-analysis. Psychiatry Res. 2019;274:228-34. [DOI:10.1016/j.psychres.2019.02.043] [PMID]
19. Ahmed A, Ali SA. Assessment of heavy metals contamination of agricultural soils using pollution indicators in Thi-Qar governorate, Southern Iraq. Univ Thi-Qar J Sci. 2023;10(2):20-6. [DOI:10.32792/utq/utjsci/v10i2.1064]
20. Mandal PK, Gaur S, Roy RG, Samkaria A, Ingole R, Goel A. Schizophrenia, bipolar and major depressive disorders: overview of clinical features, neurotransmitter alterations, pharmacological interventions, and impact of oxidative stress in the disease process. ACS Chem Neurosci. 2022;13(19):2784-802. [DOI:10.1021/acschemneuro.2c00420] [PMID]
21. Wang C, Wang H. The growing challenge of autism spectrum disorder: a comprehensive review of etiology, diagnosis, and therapy in children. All Life. 2024;17(1):2415057. [DOI:10.1080/26895293.2024.2415057]
22. Azmeraw M, Temesgen D, Kassaw A, Zemariam AB, Kerebeh G, Abebe GK, et al. The prevalence of attention-deficit hyperactivity disorder and its associated factors among children in Ethiopia, 2024: a systematic review and meta-analysis. Front Child Adolesc Psychiatry. 2024;3:1425841. [DOI:10.3389/frcha.2024.1425841] [PMID] [PMCID]
23. Bucur SM, Crișan IM, Cocoș DI, Bud ES, Galea C. Observational Study on Progressive Muscle Relaxation and Breathing Control for Reducing Dental Anxiety in Children. Medicina. 2025;61(5):876. [DOI:10.3390/medicina61050876] [PMID] [PMCID]
24. Tunn R, Boutron I, Chan AW, Collins GS, Hróbjartsson A, Moher D, et al. Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements. J Clin Epidemiol. 2024;169:111309. [DOI:10.1016/j.jclinepi.2024.111309] [PMID]
25. Krajewski K. Heavy metals, noradrenaline/adrenaline ratio, and microbiome-associated hormone precursor metabolites: biomarkers for social behaviour, ADHD symptoms, and executive function in children. Sci Rep. 2025;15(1):19006. [DOI:10.1038/s41598-025-00680-5] [PMID] [PMCID]
26. Kim Y, Kadlaskar G, Keehn RM, Keehn B. Measures of tonic and phasic activity of the locus coeruleus-norepinephrine system in children with autism spectrum disorder: An event‐related potential and pupillometry study. Autism Res. 2022;15(12):2250-64. [DOI:10.1002/aur.2820] [PMID] [PMCID]
27. Xu XJ, Cai XE, Meng FC, Song TJ, Wang XX, Wei YZ, et al. Comparison of the metabolic profiles in the plasma and urine samples between autistic and typically developing boys: a preliminary study. Front Psychiatry. 2021;12:657105. [DOI:10.3389/fpsyt.2021.657105] [PMID] [PMCID]
28. Jiahao L, Parthemore J, Revonsuo A. Can Changes in Dopamine Levels in the Brain Be Used to Influence Concentration?: A Systematic Review [Master Degree Project in Cognitive Neuroscience]. Skövde, Sweden: University of Skövde; Spring term Year 2023-24. 2024. pp.1-38.
29. Dahl MJ, Mather M, Werkle-Bergner M. Noradrenergic modulation of rhythmic neural activity shapes selective attention. Trends Cogn Sci. 2022;26(1):38-52. [DOI:10.1016/j.tics.2021.10.009] [PMID] [PMCID]
30. Szakács A. Narcolepsy in children: Relationship to the H1N1 influenza vaccination, association with psychiatric and cognitive impairments and consequences in daily life [PhD Thesis]. Gothenburg, Sweden: University of Gothenburg; 2016. pp.1-74.
31. Bouras NN, Mack NR, Gao WJ. Prefrontal modulation of anxiety through a lens of noradrenergic signaling. Front Syst Neurosci. 2023;17:1173326. [DOI:10.3389/fnsys.2023.1173326] [PMID] [PMCID]
32. Kessi M, Duan H, Xiong J, Chen B, He F, Yang L, et al. Attention-deficit/hyperactive disorder updates. Front Mol Neurosci. 2022;15:925049. [DOI:10.3389/fnmol.2022.925049] [PMID] [PMCID]
33. Ross MM, Hernandez-Espinosa DR, Aizenman E. Neurodevelopmental consequences of dietary zinc deficiency: a status report. Biol Trace Elem Res. 2023;201(12):5616-39. [DOI:10.1007/s12011-023-03630-2] [PMID]
34. do Nascimento PK, Oliveira Silva DF, de Morais TL, de Rezende AA. Zinc status and autism spectrum disorder in children and adolescents: a systematic review. Nutrients. 2023;15(16):3663. [DOI:10.3390/nu15163663] [PMID] [PMCID]
35. Robberecht H, Verlaet AA, Breynaert A, De Bruyne T, Hermans N. Magnesium, iron, zinc, copper and selenium status in attention-deficit/hyperactivity disorder (ADHD). Molecules. 2020;25(19):4440. [DOI:10.3390/molecules25194440] [PMID] [PMCID]
36. Mousain-Bosc M, Roche M, Polge A, Pradal-Prat D, Rapin J, Bali JP. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. Magnes Res. 2006;19(1):46-52.
37. Ahmadani A, Kittana M, Al-Marzooq F, Subramanya SB, D'Adamo MC, Attlee A, et al. Zinc ion dyshomeostasis in autism spectrum disorder. Nutr Res Rev. 2025:1-21. [DOI:10.1017/S095442242500006X] [PMID]
38. Kawahata I, Finkelstein DI, Fukunaga K. Dopamine D1-D5 receptors in brain nuclei: Implications for health and disease. Receptors. 2024;3(2):155-81. [DOI:10.3390/receptors3020009]
39. McWilliams S, Singh I, Leung W, Stockler S, Ipsiroglu OS. Iron deficiency and common neurodevelopmental disorders-A scoping review. PloS One. 2022;17(9):e0273819. [DOI:10.1371/journal.pone.0273819] [PMID] [PMCID]
40. Ali MW, Mahrous DM, Ebrahim NH, Marey H. Iron profile in children with ADHD. Minia J Med Res. 2025;36(2):97-105. [DOI:10.21608/mjmr.2025.375506.1932]
41. Galvez-Contreras AY, Zarate-Lopez D, Torres-Chavez AL, Gonzalez-Perez O. Role of oligodendrocytes and myelin in the pathophysiology of autism spectrum disorder. Brain Sci. 2020;10(12):951. [DOI:10.3390/brainsci10120951] [PMID] [PMCID]
42. Degremont A, Jain R, Philippou E, Latunde-Dada GO. Brain iron concentrations in the pathophysiology of children with attention deficit/hyperactivity disorder: a systematic review. Nutr Rev. 2021;79(5):615-26. [DOI:10.1093/nutrit/nuaa065] [PMID]
43. Schulze M, Coghill D, Lux S, Philipsen A, Silk T. Assessing brain Iron and its relationship to cognition and comorbidity in children with Attention-Deficit/Hyperactivity disorder with quantitative susceptibility mapping. Biol Psychiatry: Cogn Neurosci Neuroimaging. 2025;10(6):597-606. [DOI:10.1016/j.bpsc.2024.08.015] [PMID]
44. Botturi A, Ciappolino V, Delvecchio G, Boscutti A, Viscardi B, Brambilla P. The role and the effect of magnesium in mental disorders: a systematic review. Nutrients. 2020;12(6):1661. [DOI:10.3390/nu12061661] [PMID] [PMCID]
45. Visternicu M, Rarinca V, Burlui V, Halitchi G, Ciobică A, Singeap AM, et al. Investigating the impact of nutrition and oxidative stress on attention deficit hyperactivity disorder. Nutrients. 2024;16(18):3113. [DOI:10.3390/nu16183113] [PMID] [PMCID]
46. Hadjighassem M, Patoughi M. Role of Ion Channelopathy in Neurological Diseases; Role of Gabaergic System Connectivity and Dysfunction in Neurological Disorders. Int J Clin Case Rep Rev. 2024;16(1). [DOI:10.31579/2690-4861/371]
47. Kaky A, Saleh S. The Relationship Between Acetylcholinesterase, Neurotransmitter Levels, Calcium, Vitamin D3, and Trace Minerals in Autism Spectrum Disorder. Baghdad J Biochem Appl Biol Sci. 2025;6(1):46-64. [DOI:10.47419/bjbabs.v6i01.331]
48. Kiouri DP, Tsoupra E, Peana M, Perlepes SP, Stefanidou ME, Chasapis CT. Multifunctional role of zinc in human health: an update. EXCLI J. 2023;22:809.
49. Tripathy DB, Pradhan S, Gupta A, Agarwal P. Nanoparticles Induced Neurotoxicity. Nanotoxicology. 2025;19(3):325-52. [DOI:10.1080/17435390.2025.2488310] [PMID]
50. Gonzalez‐Lopez E, Vrana KE. Dopamine beta‐hydroxylase and its genetic variants in human health and disease. J Neurochem. 2020;152(2):157-81. [DOI:10.1111/jnc.14893] [PMID]

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به Journal of Advances in Medical and Biomedical Research می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2026 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb